These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The potential role of epigenetic therapy in multiple myeloma. Smith EM; Boyd K; Davies FE Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation. Amodio N; D'Aquila P; Passarino G; Tassone P; Bellizzi D Expert Opin Ther Targets; 2017 Jan; 21(1):91-101. PubMed ID: 27892767 [TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells. Ciesielski O; Biesiekierska M; Balcerczyk A Molecules; 2020 May; 25(10):. PubMed ID: 32429384 [TBL] [Abstract][Full Text] [Related]
8. Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease. Gordon JAR; Stein JL; Westendorf JJ; van Wijnen AJ Bone; 2015 Dec; 81():739-745. PubMed ID: 25836763 [TBL] [Abstract][Full Text] [Related]
9. Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development. Maleszewska M; Kaminska B Future Oncol; 2015 Sep; 11(18):2587-601. PubMed ID: 26289459 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction. Sen N Neuromolecular Med; 2015 Jun; 17(2):97-110. PubMed ID: 24777294 [TBL] [Abstract][Full Text] [Related]
11. The acetyl code in rheumatoid arthritis and other rheumatic diseases. Angiolilli C; Baeten DL; Radstake TR; Reedquist KA Epigenomics; 2017 Apr; 9(4):447-461. PubMed ID: 28102705 [TBL] [Abstract][Full Text] [Related]
12. Targeting epigenetic DNA and histone modifications to treat kidney disease. Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic modifications as novel therapeutic targets for Huntington's disease. Wang F; Fischhaber PL; Guo C; Tang TS Epigenomics; 2014 Jun; 6(3):287-97. PubMed ID: 25111483 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic Modulators as Treatment Alternative to Diverse Types of Cancer. Gutiérrez JR; Salgado ARM; Arias MÁ; San-Juan-Vergara H; Rada WR; Gómez CMM Curr Med Chem; 2022; 29(9):1503-1542. PubMed ID: 34963430 [TBL] [Abstract][Full Text] [Related]